NX Prenatal is a private molecular diagnostics company developing diagnostic assays for adverse pregnancy conditions.
NX Prenatal has raised $3.1M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2023.
NX Prenatal's investors include Keyhorse Capital.
NX Prenatal is headquartered in Louisville, United States.
NX Prenatal is a private molecular diagnostics company developing diagnostic assays for adverse pregnancy conditions.
NX Prenatal is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NX Prenatal — Funding & Investors." VCBacked, August 21, 2023, https://www.vcbacked.co/company/nx-prenatal. Accessed September 30, 2026.
VCBacked. (2023). NX Prenatal — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/nx-prenatal
{{cite web |title=NX Prenatal — Funding & Investors |url=https://www.vcbacked.co/company/nx-prenatal |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated